TABLE 1—
Area | Current Examples | Evolution |
Surveillance | Rapid and yearly assessment of 40 major birth defects. Monitoring of multiple congenital anomalies, teratogen-associated phenotypes, chromosomal anomalies, and associations with first-trimester exposure to medications | Include other outcomes (e.g., developmental disabilities); actively promote the use of data for public health action |
Public health research and information dissemination | Birth defect occurrence in relation to folic acid policies and activities; increasing rates of gastroschisis and associated factors; international impact of birth defects; aspects of human genome epidemiology; database on typical orofacial clefts | Promote etiologic studies, disease registries, research involving non-Clearinghouse members, enrollment of areas of the world for which few data are currently available; develop information and educational tools on Web site |
Program development | Increasing collaboration with other networks in Europe and the United States and with international organizations; ongoing advisory and technical support for developing programs | Develop guidelines and tools for birth defect surveillance and research for developed and developing countries, with emphasis on data sharing and regional activities |
Source. Information from http://www.icbd.org.